nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—hypertension—obesity	0.68	1	CtDrD
Eprosartan—CYP2C9—Phentermine—obesity	0.0463	0.404	CbGbCtD
Eprosartan—CYP2C9—Bupropion—obesity	0.0393	0.344	CbGbCtD
Eprosartan—CYP2C9—Cimetidine—obesity	0.0289	0.252	CbGbCtD
Eprosartan—ABCC2—bile—obesity	0.00418	0.364	CbGeAlD
Eprosartan—AGTR1—adrenal cortex—obesity	0.000835	0.0727	CbGeAlD
Eprosartan—AGTR1—cardiovascular system—obesity	0.000762	0.0663	CbGeAlD
Eprosartan—AGTR1—pituitary gland—obesity	0.000675	0.0587	CbGeAlD
Eprosartan—AGTR1—adipose tissue—obesity	0.000672	0.0585	CbGeAlD
Eprosartan—AGTR1—adrenal gland—obesity	0.000603	0.0525	CbGeAlD
Eprosartan—AGTR1—endocrine gland—obesity	0.000523	0.0455	CbGeAlD
Eprosartan—AGTR1—liver—obesity	0.000471	0.041	CbGeAlD
Eprosartan—ABCC2—digestive system—obesity	0.000457	0.0398	CbGeAlD
Eprosartan—Losartan—ACE—obesity	0.00044	0.709	CrCbGaD
Eprosartan—ABCC2—adrenal gland—obesity	0.000436	0.0379	CbGeAlD
Eprosartan—ABCC2—endocrine gland—obesity	0.000378	0.0329	CbGeAlD
Eprosartan—CYP2C9—cardiovascular system—obesity	0.000367	0.0319	CbGeAlD
Eprosartan—ABCC2—liver—obesity	0.000341	0.0297	CbGeAlD
Eprosartan—CYP2C9—digestive system—obesity	0.000305	0.0265	CbGeAlD
Eprosartan—CYP2C9—endocrine gland—obesity	0.000252	0.0219	CbGeAlD
Eprosartan—CYP2C9—liver—obesity	0.000227	0.0198	CbGeAlD
Eprosartan—Epistaxis—Bupropion—obesity	0.000193	0.00154	CcSEcCtD
Eprosartan—Polyuria—Topiramate—obesity	0.000192	0.00154	CcSEcCtD
Eprosartan—Sinusitis—Bupropion—obesity	0.000192	0.00153	CcSEcCtD
Eprosartan—Diarrhoea—Cimetidine—obesity	0.000191	0.00153	CcSEcCtD
Eprosartan—Gastroenteritis—Topiramate—obesity	0.000191	0.00153	CcSEcCtD
Eprosartan—Vascular purpura—Topiramate—obesity	0.000189	0.00151	CcSEcCtD
Eprosartan—Chills—Sibutramine—obesity	0.000189	0.00151	CcSEcCtD
Eprosartan—Eczema—Topiramate—obesity	0.000188	0.0015	CcSEcCtD
Eprosartan—Vomiting—Diethylpropion—obesity	0.000187	0.0015	CcSEcCtD
Eprosartan—Flatulence—Orlistat—obesity	0.000187	0.00149	CcSEcCtD
Eprosartan—Rash—Diethylpropion—obesity	0.000185	0.00148	CcSEcCtD
Eprosartan—Dermatitis—Diethylpropion—obesity	0.000185	0.00148	CcSEcCtD
Eprosartan—Dizziness—Cimetidine—obesity	0.000185	0.00148	CcSEcCtD
Eprosartan—Headache—Diethylpropion—obesity	0.000184	0.00147	CcSEcCtD
Eprosartan—Rhinitis—Bupropion—obesity	0.000184	0.00147	CcSEcCtD
Eprosartan—Back pain—Orlistat—obesity	0.000183	0.00147	CcSEcCtD
Eprosartan—Pharyngitis—Bupropion—obesity	0.000182	0.00146	CcSEcCtD
Eprosartan—Muscle spasms—Orlistat—obesity	0.000182	0.00146	CcSEcCtD
Eprosartan—Oedema peripheral—Bupropion—obesity	0.000181	0.00145	CcSEcCtD
Eprosartan—Hot flush—Topiramate—obesity	0.000181	0.00145	CcSEcCtD
Eprosartan—Flatulence—Sibutramine—obesity	0.00018	0.00144	CcSEcCtD
Eprosartan—Losartan—ALB—obesity	0.00018	0.291	CrCbGaD
Eprosartan—Tension—Sibutramine—obesity	0.00018	0.00144	CcSEcCtD
Eprosartan—Menopausal symptoms—Topiramate—obesity	0.000179	0.00143	CcSEcCtD
Eprosartan—Nervousness—Sibutramine—obesity	0.000178	0.00142	CcSEcCtD
Eprosartan—Vomiting—Cimetidine—obesity	0.000178	0.00142	CcSEcCtD
Eprosartan—Back pain—Sibutramine—obesity	0.000177	0.00142	CcSEcCtD
Eprosartan—Visual impairment—Bupropion—obesity	0.000177	0.00142	CcSEcCtD
Eprosartan—Rash—Cimetidine—obesity	0.000176	0.00141	CcSEcCtD
Eprosartan—Dermatitis—Cimetidine—obesity	0.000176	0.00141	CcSEcCtD
Eprosartan—Muscle spasms—Sibutramine—obesity	0.000176	0.00141	CcSEcCtD
Eprosartan—Ill-defined disorder—Orlistat—obesity	0.000176	0.00141	CcSEcCtD
Eprosartan—Headache—Cimetidine—obesity	0.000175	0.0014	CcSEcCtD
Eprosartan—Purpura—Topiramate—obesity	0.000175	0.0014	CcSEcCtD
Eprosartan—Nausea—Diethylpropion—obesity	0.000175	0.0014	CcSEcCtD
Eprosartan—Angioedema—Orlistat—obesity	0.000173	0.00138	CcSEcCtD
Eprosartan—Tremor—Sibutramine—obesity	0.000172	0.00137	CcSEcCtD
Eprosartan—Tinnitus—Bupropion—obesity	0.000171	0.00137	CcSEcCtD
Eprosartan—Malaise—Orlistat—obesity	0.000171	0.00137	CcSEcCtD
Eprosartan—Vertigo—Orlistat—obesity	0.00017	0.00136	CcSEcCtD
Eprosartan—Ill-defined disorder—Sibutramine—obesity	0.00017	0.00136	CcSEcCtD
Eprosartan—Hyponatraemia—Topiramate—obesity	0.00017	0.00136	CcSEcCtD
Eprosartan—Osteoarthritis—Topiramate—obesity	0.000169	0.00135	CcSEcCtD
Eprosartan—Angioedema—Sibutramine—obesity	0.000167	0.00134	CcSEcCtD
Eprosartan—Palpitations—Orlistat—obesity	0.000167	0.00134	CcSEcCtD
Eprosartan—Migraine—Topiramate—obesity	0.000166	0.00133	CcSEcCtD
Eprosartan—Nausea—Cimetidine—obesity	0.000166	0.00133	CcSEcCtD
Eprosartan—Malaise—Sibutramine—obesity	0.000165	0.00132	CcSEcCtD
Eprosartan—Cough—Orlistat—obesity	0.000165	0.00132	CcSEcCtD
Eprosartan—Chills—Bupropion—obesity	0.000165	0.00132	CcSEcCtD
Eprosartan—Vertigo—Sibutramine—obesity	0.000165	0.00132	CcSEcCtD
Eprosartan—Syncope—Sibutramine—obesity	0.000164	0.00131	CcSEcCtD
Eprosartan—Face oedema—Topiramate—obesity	0.000163	0.00131	CcSEcCtD
Eprosartan—Palpitations—Sibutramine—obesity	0.000162	0.0013	CcSEcCtD
Eprosartan—Chest pain—Orlistat—obesity	0.000161	0.00129	CcSEcCtD
Eprosartan—Myalgia—Orlistat—obesity	0.000161	0.00129	CcSEcCtD
Eprosartan—Loss of consciousness—Sibutramine—obesity	0.000161	0.00129	CcSEcCtD
Eprosartan—Anxiety—Orlistat—obesity	0.000161	0.00129	CcSEcCtD
Eprosartan—Cough—Sibutramine—obesity	0.00016	0.00128	CcSEcCtD
Eprosartan—Discomfort—Orlistat—obesity	0.000159	0.00127	CcSEcCtD
Eprosartan—Ataxia—Topiramate—obesity	0.000159	0.00127	CcSEcCtD
Eprosartan—Blood creatinine increased—Topiramate—obesity	0.000158	0.00127	CcSEcCtD
Eprosartan—Dry mouth—Orlistat—obesity	0.000158	0.00126	CcSEcCtD
Eprosartan—Flatulence—Bupropion—obesity	0.000157	0.00126	CcSEcCtD
Eprosartan—Tension—Bupropion—obesity	0.000157	0.00125	CcSEcCtD
Eprosartan—Chest pain—Sibutramine—obesity	0.000156	0.00125	CcSEcCtD
Eprosartan—Arthralgia—Sibutramine—obesity	0.000156	0.00125	CcSEcCtD
Eprosartan—Myalgia—Sibutramine—obesity	0.000156	0.00125	CcSEcCtD
Eprosartan—Anxiety—Sibutramine—obesity	0.000155	0.00124	CcSEcCtD
Eprosartan—Nervousness—Bupropion—obesity	0.000155	0.00124	CcSEcCtD
Eprosartan—Back pain—Bupropion—obesity	0.000154	0.00124	CcSEcCtD
Eprosartan—Orthostatic hypotension—Topiramate—obesity	0.000154	0.00124	CcSEcCtD
Eprosartan—Discomfort—Sibutramine—obesity	0.000154	0.00123	CcSEcCtD
Eprosartan—Hypokalaemia—Topiramate—obesity	0.000154	0.00123	CcSEcCtD
Eprosartan—Muscle spasms—Bupropion—obesity	0.000154	0.00123	CcSEcCtD
Eprosartan—Dry mouth—Sibutramine—obesity	0.000153	0.00122	CcSEcCtD
Eprosartan—Aspartate aminotransferase increased—Topiramate—obesity	0.000152	0.00122	CcSEcCtD
Eprosartan—Tremor—Bupropion—obesity	0.00015	0.0012	CcSEcCtD
Eprosartan—Gastritis—Topiramate—obesity	0.00015	0.0012	CcSEcCtD
Eprosartan—Hyperhidrosis—Orlistat—obesity	0.000149	0.0012	CcSEcCtD
Eprosartan—Alanine aminotransferase increased—Topiramate—obesity	0.000149	0.00119	CcSEcCtD
Eprosartan—Muscular weakness—Topiramate—obesity	0.000149	0.00119	CcSEcCtD
Eprosartan—Ill-defined disorder—Bupropion—obesity	0.000148	0.00119	CcSEcCtD
Eprosartan—Shock—Sibutramine—obesity	0.000147	0.00118	CcSEcCtD
Eprosartan—Thrombocytopenia—Sibutramine—obesity	0.000146	0.00117	CcSEcCtD
Eprosartan—Asthma—Topiramate—obesity	0.000146	0.00117	CcSEcCtD
Eprosartan—Angioedema—Bupropion—obesity	0.000146	0.00117	CcSEcCtD
Eprosartan—Tachycardia—Sibutramine—obesity	0.000146	0.00117	CcSEcCtD
Eprosartan—Hyperhidrosis—Sibutramine—obesity	0.000145	0.00116	CcSEcCtD
Eprosartan—Malaise—Bupropion—obesity	0.000144	0.00115	CcSEcCtD
Eprosartan—Vertigo—Bupropion—obesity	0.000143	0.00115	CcSEcCtD
Eprosartan—Syncope—Bupropion—obesity	0.000143	0.00115	CcSEcCtD
Eprosartan—Anorexia—Sibutramine—obesity	0.000142	0.00114	CcSEcCtD
Eprosartan—Sweating increased—Topiramate—obesity	0.000142	0.00114	CcSEcCtD
Eprosartan—Angina pectoris—Topiramate—obesity	0.000142	0.00114	CcSEcCtD
Eprosartan—Palpitations—Bupropion—obesity	0.000141	0.00113	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Orlistat—obesity	0.000141	0.00113	CcSEcCtD
Eprosartan—Bronchitis—Topiramate—obesity	0.00014	0.00112	CcSEcCtD
Eprosartan—Loss of consciousness—Bupropion—obesity	0.00014	0.00112	CcSEcCtD
Eprosartan—Insomnia—Orlistat—obesity	0.00014	0.00112	CcSEcCtD
Eprosartan—Hypotension—Sibutramine—obesity	0.00014	0.00112	CcSEcCtD
Eprosartan—Cough—Bupropion—obesity	0.000139	0.00112	CcSEcCtD
Eprosartan—Paraesthesia—Orlistat—obesity	0.000139	0.00111	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Sibutramine—obesity	0.000136	0.00109	CcSEcCtD
Eprosartan—Dyspepsia—Orlistat—obesity	0.000136	0.00109	CcSEcCtD
Eprosartan—Myalgia—Bupropion—obesity	0.000136	0.00109	CcSEcCtD
Eprosartan—Chest pain—Bupropion—obesity	0.000136	0.00109	CcSEcCtD
Eprosartan—Arthralgia—Bupropion—obesity	0.000136	0.00109	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Topiramate—obesity	0.000136	0.00109	CcSEcCtD
Eprosartan—Anxiety—Bupropion—obesity	0.000135	0.00108	CcSEcCtD
Eprosartan—Insomnia—Sibutramine—obesity	0.000135	0.00108	CcSEcCtD
Eprosartan—Pollakiuria—Topiramate—obesity	0.000135	0.00108	CcSEcCtD
Eprosartan—Discomfort—Bupropion—obesity	0.000134	0.00108	CcSEcCtD
Eprosartan—Decreased appetite—Orlistat—obesity	0.000134	0.00107	CcSEcCtD
Eprosartan—Paraesthesia—Sibutramine—obesity	0.000134	0.00107	CcSEcCtD
Eprosartan—Dyspnoea—Sibutramine—obesity	0.000133	0.00107	CcSEcCtD
Eprosartan—Fatigue—Orlistat—obesity	0.000133	0.00107	CcSEcCtD
Eprosartan—Dry mouth—Bupropion—obesity	0.000133	0.00106	CcSEcCtD
Eprosartan—Somnolence—Sibutramine—obesity	0.000133	0.00106	CcSEcCtD
Eprosartan—Pain—Orlistat—obesity	0.000132	0.00106	CcSEcCtD
Eprosartan—Hyperglycaemia—Topiramate—obesity	0.000132	0.00105	CcSEcCtD
Eprosartan—Dyspepsia—Sibutramine—obesity	0.000132	0.00105	CcSEcCtD
Eprosartan—Decreased appetite—Sibutramine—obesity	0.00013	0.00104	CcSEcCtD
Eprosartan—Depression—Topiramate—obesity	0.00013	0.00104	CcSEcCtD
Eprosartan—Shock—Bupropion—obesity	0.000128	0.00103	CcSEcCtD
Eprosartan—Renal failure—Topiramate—obesity	0.000128	0.00102	CcSEcCtD
Eprosartan—Pain—Sibutramine—obesity	0.000128	0.00102	CcSEcCtD
Eprosartan—Constipation—Sibutramine—obesity	0.000128	0.00102	CcSEcCtD
Eprosartan—Neuropathy peripheral—Topiramate—obesity	0.000128	0.00102	CcSEcCtD
Eprosartan—Thrombocytopenia—Bupropion—obesity	0.000128	0.00102	CcSEcCtD
Eprosartan—Feeling abnormal—Orlistat—obesity	0.000127	0.00102	CcSEcCtD
Eprosartan—Tachycardia—Bupropion—obesity	0.000127	0.00102	CcSEcCtD
Eprosartan—Urinary tract infection—Topiramate—obesity	0.000127	0.00101	CcSEcCtD
Eprosartan—Conjunctivitis—Topiramate—obesity	0.000127	0.00101	CcSEcCtD
Eprosartan—Gastrointestinal pain—Orlistat—obesity	0.000126	0.00101	CcSEcCtD
Eprosartan—Hyperhidrosis—Bupropion—obesity	0.000126	0.00101	CcSEcCtD
Eprosartan—Anorexia—Bupropion—obesity	0.000124	0.000994	CcSEcCtD
Eprosartan—Haematuria—Topiramate—obesity	0.000124	0.000994	CcSEcCtD
Eprosartan—Feeling abnormal—Sibutramine—obesity	0.000123	0.000986	CcSEcCtD
Eprosartan—Epistaxis—Topiramate—obesity	0.000123	0.000983	CcSEcCtD
Eprosartan—Urticaria—Orlistat—obesity	0.000123	0.000982	CcSEcCtD
Eprosartan—Gastrointestinal pain—Sibutramine—obesity	0.000122	0.000979	CcSEcCtD
Eprosartan—Sinusitis—Topiramate—obesity	0.000122	0.000978	CcSEcCtD
Eprosartan—Abdominal pain—Orlistat—obesity	0.000122	0.000978	CcSEcCtD
Eprosartan—Body temperature increased—Orlistat—obesity	0.000122	0.000978	CcSEcCtD
Eprosartan—Hypotension—Bupropion—obesity	0.000122	0.000975	CcSEcCtD
Eprosartan—Bradycardia—Topiramate—obesity	0.000119	0.000952	CcSEcCtD
Eprosartan—Urticaria—Sibutramine—obesity	0.000119	0.000951	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Bupropion—obesity	0.000119	0.000951	CcSEcCtD
Eprosartan—Abdominal pain—Sibutramine—obesity	0.000118	0.000946	CcSEcCtD
Eprosartan—Body temperature increased—Sibutramine—obesity	0.000118	0.000946	CcSEcCtD
Eprosartan—Insomnia—Bupropion—obesity	0.000118	0.000944	CcSEcCtD
Eprosartan—Rhinitis—Topiramate—obesity	0.000117	0.000938	CcSEcCtD
Eprosartan—Paraesthesia—Bupropion—obesity	0.000117	0.000937	CcSEcCtD
Eprosartan—Dyspnoea—Bupropion—obesity	0.000116	0.00093	CcSEcCtD
Eprosartan—Pharyngitis—Topiramate—obesity	0.000116	0.000929	CcSEcCtD
Eprosartan—Somnolence—Bupropion—obesity	0.000116	0.000927	CcSEcCtD
Eprosartan—Oedema peripheral—Topiramate—obesity	0.000115	0.000922	CcSEcCtD
Eprosartan—Dyspepsia—Bupropion—obesity	0.000115	0.000918	CcSEcCtD
Eprosartan—Hypersensitivity—Orlistat—obesity	0.000114	0.000911	CcSEcCtD
Eprosartan—Decreased appetite—Bupropion—obesity	0.000113	0.000907	CcSEcCtD
Eprosartan—Visual impairment—Topiramate—obesity	0.000113	0.000902	CcSEcCtD
Eprosartan—Fatigue—Bupropion—obesity	0.000112	0.000899	CcSEcCtD
Eprosartan—Pain—Bupropion—obesity	0.000111	0.000892	CcSEcCtD
Eprosartan—Constipation—Bupropion—obesity	0.000111	0.000892	CcSEcCtD
Eprosartan—Asthenia—Orlistat—obesity	0.000111	0.000887	CcSEcCtD
Eprosartan—Hypersensitivity—Sibutramine—obesity	0.00011	0.000882	CcSEcCtD
Eprosartan—Pruritus—Orlistat—obesity	0.000109	0.000875	CcSEcCtD
Eprosartan—Tinnitus—Topiramate—obesity	0.000109	0.000872	CcSEcCtD
Eprosartan—Feeling abnormal—Bupropion—obesity	0.000107	0.00086	CcSEcCtD
Eprosartan—Asthenia—Sibutramine—obesity	0.000107	0.000859	CcSEcCtD
Eprosartan—Gastrointestinal pain—Bupropion—obesity	0.000107	0.000853	CcSEcCtD
Eprosartan—Pruritus—Sibutramine—obesity	0.000106	0.000847	CcSEcCtD
Eprosartan—Diarrhoea—Orlistat—obesity	0.000106	0.000846	CcSEcCtD
Eprosartan—Chills—Topiramate—obesity	0.000105	0.000839	CcSEcCtD
Eprosartan—Urticaria—Bupropion—obesity	0.000104	0.000829	CcSEcCtD
Eprosartan—Body temperature increased—Bupropion—obesity	0.000103	0.000825	CcSEcCtD
Eprosartan—Abdominal pain—Bupropion—obesity	0.000103	0.000825	CcSEcCtD
Eprosartan—Diarrhoea—Sibutramine—obesity	0.000102	0.000819	CcSEcCtD
Eprosartan—Dizziness—Orlistat—obesity	0.000102	0.000818	CcSEcCtD
Eprosartan—Flatulence—Topiramate—obesity	0.0001	0.000803	CcSEcCtD
Eprosartan—Tension—Topiramate—obesity	9.98e-05	0.000799	CcSEcCtD
Eprosartan—Dizziness—Sibutramine—obesity	9.89e-05	0.000791	CcSEcCtD
Eprosartan—Nervousness—Topiramate—obesity	9.88e-05	0.000791	CcSEcCtD
Eprosartan—Back pain—Topiramate—obesity	9.84e-05	0.000788	CcSEcCtD
Eprosartan—Vomiting—Orlistat—obesity	9.82e-05	0.000786	CcSEcCtD
Eprosartan—Muscle spasms—Topiramate—obesity	9.78e-05	0.000783	CcSEcCtD
Eprosartan—Rash—Orlistat—obesity	9.74e-05	0.00078	CcSEcCtD
Eprosartan—Dermatitis—Orlistat—obesity	9.73e-05	0.000779	CcSEcCtD
Eprosartan—Headache—Orlistat—obesity	9.68e-05	0.000775	CcSEcCtD
Eprosartan—Hypersensitivity—Bupropion—obesity	9.6e-05	0.000769	CcSEcCtD
Eprosartan—Tremor—Topiramate—obesity	9.53e-05	0.000763	CcSEcCtD
Eprosartan—Vomiting—Sibutramine—obesity	9.51e-05	0.000761	CcSEcCtD
Eprosartan—Ill-defined disorder—Topiramate—obesity	9.44e-05	0.000756	CcSEcCtD
Eprosartan—Rash—Sibutramine—obesity	9.43e-05	0.000755	CcSEcCtD
Eprosartan—Dermatitis—Sibutramine—obesity	9.42e-05	0.000754	CcSEcCtD
Eprosartan—Headache—Sibutramine—obesity	9.37e-05	0.00075	CcSEcCtD
Eprosartan—Asthenia—Bupropion—obesity	9.35e-05	0.000749	CcSEcCtD
Eprosartan—Pruritus—Bupropion—obesity	9.22e-05	0.000738	CcSEcCtD
Eprosartan—Nausea—Orlistat—obesity	9.18e-05	0.000735	CcSEcCtD
Eprosartan—Malaise—Topiramate—obesity	9.17e-05	0.000734	CcSEcCtD
Eprosartan—Vertigo—Topiramate—obesity	9.14e-05	0.000732	CcSEcCtD
Eprosartan—Syncope—Topiramate—obesity	9.12e-05	0.00073	CcSEcCtD
Eprosartan—Palpitations—Topiramate—obesity	8.99e-05	0.00072	CcSEcCtD
Eprosartan—Loss of consciousness—Topiramate—obesity	8.94e-05	0.000716	CcSEcCtD
Eprosartan—Diarrhoea—Bupropion—obesity	8.92e-05	0.000714	CcSEcCtD
Eprosartan—Nausea—Sibutramine—obesity	8.88e-05	0.000711	CcSEcCtD
Eprosartan—Cough—Topiramate—obesity	8.88e-05	0.000711	CcSEcCtD
Eprosartan—Arthralgia—Topiramate—obesity	8.66e-05	0.000693	CcSEcCtD
Eprosartan—Myalgia—Topiramate—obesity	8.66e-05	0.000693	CcSEcCtD
Eprosartan—Chest pain—Topiramate—obesity	8.66e-05	0.000693	CcSEcCtD
Eprosartan—Anxiety—Topiramate—obesity	8.63e-05	0.000691	CcSEcCtD
Eprosartan—Dizziness—Bupropion—obesity	8.62e-05	0.00069	CcSEcCtD
Eprosartan—Discomfort—Topiramate—obesity	8.56e-05	0.000685	CcSEcCtD
Eprosartan—Dry mouth—Topiramate—obesity	8.47e-05	0.000678	CcSEcCtD
Eprosartan—Vomiting—Bupropion—obesity	8.29e-05	0.000663	CcSEcCtD
Eprosartan—Rash—Bupropion—obesity	8.22e-05	0.000658	CcSEcCtD
Eprosartan—Dermatitis—Bupropion—obesity	8.21e-05	0.000657	CcSEcCtD
Eprosartan—Shock—Topiramate—obesity	8.17e-05	0.000654	CcSEcCtD
Eprosartan—Headache—Bupropion—obesity	8.16e-05	0.000654	CcSEcCtD
Eprosartan—Thrombocytopenia—Topiramate—obesity	8.13e-05	0.000651	CcSEcCtD
Eprosartan—Tachycardia—Topiramate—obesity	8.1e-05	0.000649	CcSEcCtD
Eprosartan—Hyperhidrosis—Topiramate—obesity	8.03e-05	0.000643	CcSEcCtD
Eprosartan—Anorexia—Topiramate—obesity	7.91e-05	0.000634	CcSEcCtD
Eprosartan—Hypotension—Topiramate—obesity	7.76e-05	0.000621	CcSEcCtD
Eprosartan—Nausea—Bupropion—obesity	7.74e-05	0.00062	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Topiramate—obesity	7.56e-05	0.000606	CcSEcCtD
Eprosartan—Insomnia—Topiramate—obesity	7.51e-05	0.000601	CcSEcCtD
Eprosartan—Paraesthesia—Topiramate—obesity	7.46e-05	0.000597	CcSEcCtD
Eprosartan—Dyspnoea—Topiramate—obesity	7.4e-05	0.000593	CcSEcCtD
Eprosartan—Somnolence—Topiramate—obesity	7.38e-05	0.000591	CcSEcCtD
Eprosartan—Dyspepsia—Topiramate—obesity	7.31e-05	0.000585	CcSEcCtD
Eprosartan—Decreased appetite—Topiramate—obesity	7.22e-05	0.000578	CcSEcCtD
Eprosartan—Fatigue—Topiramate—obesity	7.16e-05	0.000573	CcSEcCtD
Eprosartan—Constipation—Topiramate—obesity	7.1e-05	0.000568	CcSEcCtD
Eprosartan—Pain—Topiramate—obesity	7.1e-05	0.000568	CcSEcCtD
Eprosartan—Feeling abnormal—Topiramate—obesity	6.84e-05	0.000548	CcSEcCtD
Eprosartan—Gastrointestinal pain—Topiramate—obesity	6.79e-05	0.000544	CcSEcCtD
Eprosartan—Urticaria—Topiramate—obesity	6.6e-05	0.000528	CcSEcCtD
Eprosartan—Body temperature increased—Topiramate—obesity	6.56e-05	0.000525	CcSEcCtD
Eprosartan—Abdominal pain—Topiramate—obesity	6.56e-05	0.000525	CcSEcCtD
Eprosartan—Hypersensitivity—Topiramate—obesity	6.12e-05	0.00049	CcSEcCtD
Eprosartan—Asthenia—Topiramate—obesity	5.96e-05	0.000477	CcSEcCtD
Eprosartan—Pruritus—Topiramate—obesity	5.87e-05	0.00047	CcSEcCtD
Eprosartan—Diarrhoea—Topiramate—obesity	5.68e-05	0.000455	CcSEcCtD
Eprosartan—Dizziness—Topiramate—obesity	5.49e-05	0.00044	CcSEcCtD
Eprosartan—Vomiting—Topiramate—obesity	5.28e-05	0.000423	CcSEcCtD
Eprosartan—Rash—Topiramate—obesity	5.24e-05	0.000419	CcSEcCtD
Eprosartan—Dermatitis—Topiramate—obesity	5.23e-05	0.000419	CcSEcCtD
Eprosartan—Headache—Topiramate—obesity	5.2e-05	0.000416	CcSEcCtD
Eprosartan—Nausea—Topiramate—obesity	4.93e-05	0.000395	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—PRKCD—obesity	2.09e-05	0.000304	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AKR1C3—obesity	2.06e-05	0.0003	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR2A—obesity	2.04e-05	0.000298	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—C3—obesity	2.04e-05	0.000297	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LPA—obesity	2.03e-05	0.000296	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NPS—obesity	2.01e-05	0.000292	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—INPP5E—obesity	1.99e-05	0.000291	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GPT—obesity	1.99e-05	0.000291	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—UQCRC2—obesity	1.99e-05	0.000291	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LPIN1—obesity	1.99e-05	0.00029	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—F2—obesity	1.97e-05	0.000288	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PRKCB—obesity	1.97e-05	0.000288	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR2C—obesity	1.97e-05	0.000287	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DRD1—obesity	1.97e-05	0.000287	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—obesity	1.95e-05	0.000284	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AGT—obesity	1.94e-05	0.000283	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NTRK2—obesity	1.91e-05	0.000279	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADRB1—obesity	1.9e-05	0.000278	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PIK3CG—obesity	1.89e-05	0.000275	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—PPARA—obesity	1.88e-05	0.000275	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PARP1—obesity	1.86e-05	0.000272	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GHRL—obesity	1.86e-05	0.000272	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CLOCK—obesity	1.86e-05	0.000271	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ME1—obesity	1.85e-05	0.00027	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALDH6A1—obesity	1.85e-05	0.00027	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SUCLG2—obesity	1.85e-05	0.00027	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DRD4—obesity	1.85e-05	0.00027	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—POMC—obesity	1.85e-05	0.000269	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—obesity	1.81e-05	0.000264	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—POMC—obesity	1.8e-05	0.000262	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—F2—obesity	1.79e-05	0.000261	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PRKCB—obesity	1.79e-05	0.000261	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—APOA1—obesity	1.77e-05	0.000258	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CNR1—obesity	1.77e-05	0.000258	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—COX7C—obesity	1.74e-05	0.000254	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—UCP1—obesity	1.74e-05	0.000254	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PNPLA3—obesity	1.74e-05	0.000254	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TCF7L2—obesity	1.73e-05	0.000253	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AKT2—obesity	1.73e-05	0.000252	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DRD2—obesity	1.72e-05	0.000251	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PIK3CG—obesity	1.71e-05	0.00025	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GCG—obesity	1.71e-05	0.000249	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PTPN1—obesity	1.71e-05	0.000249	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PIK3CD—obesity	1.66e-05	0.000242	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—obesity	1.66e-05	0.000242	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DGAT2—obesity	1.65e-05	0.000241	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CS—obesity	1.65e-05	0.000241	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SUCLA2—obesity	1.65e-05	0.000241	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CPS1—obesity	1.65e-05	0.000241	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—POMC—obesity	1.63e-05	0.000238	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRL—obesity	1.63e-05	0.000237	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—obesity	1.61e-05	0.000235	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—obesity	1.6e-05	0.000234	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—STK11—obesity	1.6e-05	0.000234	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL2—obesity	1.6e-05	0.000233	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PLG—obesity	1.59e-05	0.000231	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—RHOA—obesity	1.58e-05	0.000231	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LIPE—obesity	1.58e-05	0.00023	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MUT—obesity	1.58e-05	0.00023	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AKT2—obesity	1.57e-05	0.000229	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PIK3R1—obesity	1.57e-05	0.000228	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CETP—obesity	1.56e-05	0.000227	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FOXO3—obesity	1.55e-05	0.000226	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADRB2—obesity	1.54e-05	0.000225	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—obesity	1.54e-05	0.000225	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SOCS1—obesity	1.52e-05	0.000222	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—obesity	1.51e-05	0.000221	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYB5A—obesity	1.51e-05	0.00022	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DGAT1—obesity	1.51e-05	0.00022	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PIK3CD—obesity	1.51e-05	0.00022	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SOCS3—obesity	1.5e-05	0.000219	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—obesity	1.49e-05	0.000218	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GNB3—obesity	1.47e-05	0.000214	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ACLY—obesity	1.45e-05	0.000212	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—TYK2—obesity	1.45e-05	0.000211	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—obesity	1.45e-05	0.000211	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PIK3CB—obesity	1.45e-05	0.000211	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IGF2—obesity	1.44e-05	0.000211	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—RHOA—obesity	1.44e-05	0.00021	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GNAS—obesity	1.43e-05	0.000209	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PIK3R1—obesity	1.42e-05	0.000207	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ENPP1—obesity	1.4e-05	0.000205	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALOX12—obesity	1.4e-05	0.000205	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APOB—obesity	1.4e-05	0.000204	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ALB—obesity	1.4e-05	0.000204	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—FASN—obesity	1.38e-05	0.000201	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—obesity	1.37e-05	0.0002	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL5—obesity	1.37e-05	0.0002	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HMGCS1—obesity	1.36e-05	0.000198	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LPL—obesity	1.34e-05	0.000195	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FOXO1—obesity	1.33e-05	0.000194	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RPS6KB1—obesity	1.33e-05	0.000193	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ACADM—obesity	1.32e-05	0.000193	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PFKFB3—obesity	1.32e-05	0.000193	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ANGPTL4—obesity	1.32e-05	0.000193	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PNPLA2—obesity	1.32e-05	0.000193	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLIN1—obesity	1.32e-05	0.000193	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SAT1—obesity	1.32e-05	0.000193	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PIK3CB—obesity	1.31e-05	0.000191	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—OXCT1—obesity	1.28e-05	0.000187	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ACACB—obesity	1.28e-05	0.000187	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYTB—obesity	1.28e-05	0.000187	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SRD5A1—obesity	1.25e-05	0.000183	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PNLIP—obesity	1.25e-05	0.000183	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRKCD—obesity	1.23e-05	0.00018	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SDC3—obesity	1.22e-05	0.000178	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—obesity	1.22e-05	0.000177	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR2A—obesity	1.21e-05	0.000176	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—C3—obesity	1.2e-05	0.000176	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—obesity	1.2e-05	0.000175	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—STS—obesity	1.19e-05	0.000174	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HK2—obesity	1.19e-05	0.000174	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP26B1—obesity	1.19e-05	0.000174	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—obesity	1.18e-05	0.000172	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARD—obesity	1.17e-05	0.00017	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IRS2—obesity	1.15e-05	0.000167	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC27A1—obesity	1.14e-05	0.000167	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AGT—obesity	1.14e-05	0.000167	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GLUL—obesity	1.12e-05	0.000164	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—FABP4—obesity	1.12e-05	0.000164	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LEP—obesity	1.12e-05	0.000164	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APOE—obesity	1.12e-05	0.000164	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CAV1—obesity	1.11e-05	0.000162	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APOA1—obesity	1.11e-05	0.000162	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	1.08e-05	0.000158	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ESR1—obesity	1.07e-05	0.000156	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—UCP2—obesity	1.06e-05	0.000155	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ECHS1—obesity	1.06e-05	0.000155	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HSD11B1—obesity	1.06e-05	0.000155	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—UCP3—obesity	1.06e-05	0.000155	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—F2—obesity	1.06e-05	0.000154	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRKCB—obesity	1.06e-05	0.000154	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ADH1B—obesity	1.05e-05	0.000153	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—BAD—obesity	1.05e-05	0.000152	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOB—obesity	1.03e-05	0.00015	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARGC1B—obesity	1.03e-05	0.00015	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GPAM—obesity	1.03e-05	0.00015	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ACSL1—obesity	1.03e-05	0.00015	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PIK3CG—obesity	1.01e-05	0.000148	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HADH—obesity	1e-05	0.000146	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—FADS1—obesity	1e-05	0.000146	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PCK1—obesity	1e-05	0.000146	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IRS1—obesity	1e-05	0.000146	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—obesity	9.85e-06	0.000144	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ACP5—obesity	9.73e-06	0.000142	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—POMC—obesity	9.63e-06	0.000141	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—obesity	9.61e-06	0.00014	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—INS—obesity	9.58e-06	0.00014	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—G6PD—obesity	9.49e-06	0.000138	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL2—obesity	9.43e-06	0.000138	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HK1—obesity	9.37e-06	0.000137	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SREBF2—obesity	9.37e-06	0.000137	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—obesity	9.36e-06	0.000137	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IGF1—obesity	9.27e-06	0.000135	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AKT2—obesity	9.26e-06	0.000135	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LPA—obesity	9.05e-06	0.000132	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PIK3CD—obesity	8.9e-06	0.00013	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LPIN1—obesity	8.86e-06	0.000129	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PIK3CA—obesity	8.81e-06	0.000129	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SERPINE1—obesity	8.8e-06	0.000128	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—obesity	8.7e-06	0.000127	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOA5—obesity	8.68e-06	0.000127	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TYK2—obesity	8.56e-06	0.000125	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RHOA—obesity	8.49e-06	0.000124	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—obesity	8.43e-06	0.000123	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PIK3R1—obesity	8.4e-06	0.000123	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NOS3—obesity	8.4e-06	0.000123	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CLOCK—obesity	8.28e-06	0.000121	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC22A1—obesity	8.28e-06	0.000121	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—obesity	8.26e-06	0.00012	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—obesity	8.18e-06	0.000119	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—obesity	8.16e-06	0.000119	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SULT2A1—obesity	8.07e-06	0.000118	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GLP1R—obesity	8.07e-06	0.000118	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PIK3CA—obesity	8e-06	0.000117	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DPYD—obesity	7.93e-06	0.000116	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PIK3CB—obesity	7.76e-06	0.000113	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MTOR—obesity	7.76e-06	0.000113	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PRKAR2B—obesity	7.64e-06	0.000111	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DCN—obesity	7.58e-06	0.000111	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—obesity	7.45e-06	0.000109	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CPT1A—obesity	7.38e-06	0.000108	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NAMPT—obesity	7.23e-06	0.000106	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AKT1—obesity	7.2e-06	0.000105	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—obesity	7.19e-06	0.000105	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LIPC—obesity	7.19e-06	0.000105	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GCK—obesity	7.19e-06	0.000105	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOC3—obesity	7.14e-06	0.000104	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—obesity	7.09e-06	0.000103	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6—obesity	7.09e-06	0.000103	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CETP—obesity	6.94e-06	0.000101	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SDC1—obesity	6.86e-06	0.0001	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AKR1C3—obesity	6.75e-06	9.84e-05	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP9—obesity	6.74e-06	9.83e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SCARB1—obesity	6.64e-06	9.69e-05	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MAPK8—obesity	6.56e-06	9.56e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—obesity	6.55e-06	9.56e-05	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AKT1—obesity	6.54e-06	9.54e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—obesity	6.47e-06	9.43e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SREBF1—obesity	6.45e-06	9.41e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GOT2—obesity	6.27e-06	9.15e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—obesity	6.19e-06	9.02e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—FASN—obesity	6.14e-06	8.95e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—BCHE—obesity	6.11e-06	8.92e-05	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—STAT3—obesity	5.99e-06	8.74e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP2E1—obesity	5.9e-06	8.6e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NQO1—obesity	5.83e-06	8.51e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—obesity	5.71e-06	8.33e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—obesity	5.66e-06	8.25e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC2A4—obesity	5.59e-06	8.15e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GCG—obesity	5.59e-06	8.15e-05	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MYC—obesity	5.57e-06	8.12e-05	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TGFB1—obesity	5.56e-06	8.1e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYCS—obesity	5.52e-06	8.05e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GGT1—obesity	5.41e-06	7.9e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GOT1—obesity	5.41e-06	7.9e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NCOA1—obesity	5.33e-06	7.78e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—STK11—obesity	5.26e-06	7.67e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP19A1—obesity	5.26e-06	7.67e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—COMT—obesity	4.89e-06	7.13e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARGC1A—obesity	4.82e-06	7.03e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GNB3—obesity	4.82e-06	7.03e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HMOX1—obesity	4.8e-06	7e-05	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PIK3CA—obesity	4.73e-06	6.9e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GNAS—obesity	4.69e-06	6.84e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOB—obesity	4.59e-06	6.7e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LPL—obesity	4.39e-06	6.4e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GPX1—obesity	4.28e-06	6.24e-05	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6—obesity	4.19e-06	6.11e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CD36—obesity	4.17e-06	6.08e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MTHFR—obesity	3.95e-06	5.76e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARA—obesity	3.88e-06	5.65e-05	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AKT1—obesity	3.86e-06	5.63e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AGT—obesity	3.75e-06	5.47e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOE—obesity	3.68e-06	5.36e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CAV1—obesity	3.64e-06	5.31e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOA1—obesity	3.64e-06	5.3e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.48e-06	5.08e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIK3CG—obesity	3.32e-06	4.84e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARG—obesity	3.2e-06	4.67e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—POMC—obesity	3.16e-06	4.61e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—INS—obesity	3.14e-06	4.58e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIK3CD—obesity	2.92e-06	4.26e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALB—obesity	2.88e-06	4.2e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NOS3—obesity	2.75e-06	4.02e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIK3R1—obesity	2.75e-06	4.02e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIK3CB—obesity	2.54e-06	3.71e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGS2—obesity	2.52e-06	3.68e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIK3CA—obesity	1.55e-06	2.26e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AKT1—obesity	1.27e-06	1.85e-05	CbGpPWpGaD
